Loading...
NYSE: ELV
Elevance Health Inc.
Healthcare · Medical - Healthcare Plans
●S&P 500 since 2002
Market Cap
$65.10B
52w High
$458.75
52w Low
$273.71
P/E
11.55
Volume
1.26M
Outstanding Shares
220.71M
Company profile
Elevance Health Inc. operates as a health benefits company.
CEOGail Koziara Boudreaux
SectorHealthcare
IndustryMedical - Healthcare Plans
Employees104,200
IPO dateOct 30, 2001
Valuation
Forward P/E—
EV/EBITDA10.51
Enterprise value$101.5B
Price / Book1.48
Stock splits
Jun 1, 20052:1
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth9.47%
Gross margin25.56%▼8.22%vs FY2024
Operating margin4.07%▼18.96%vs FY2024
ROE12.9%▼10.86%vs FY2024
Analyst consensus
RatingBuy
Target price$382.64▲29.73%
26
Buy
11
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 28, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$8.84
$8.91
Q3FY25
ActualEst.
$6.03
$4.93
Q4FY25
ActualEst.
$3.33
$3.10
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$49.78B
$48.19B
Q3FY25
ActualEst.
$50.71B
$49.38B
Q4FY25
ActualEst.
$49.75B
$49.84B
Q1FY26
Next Est.
—